Swiss National Bank’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.14M | Buy |
218,200
+5,400
| +3% | +$138K | ﹤0.01% | 1358 |
|
|
2025
Q4 | $6.18M | Buy |
212,800
+4,900
| +2% | +$125K | ﹤0.01% | 1238 |
|
|
2025
Q3 | $3.92M | Buy |
207,900
+3,900
| +2% | +$61.5K | ﹤0.01% | 1458 |
|
|
2025
Q2 | $2.86M | Hold |
204,000
| – | – | ﹤0.01% | 1597 |
|
|
2025
Q1 | $3.19M | Sell |
204,000
-2,900
| -1% | -$40.9K | ﹤0.01% | 1510 |
|
|
2024
Q4 | $2.88M | Buy |
206,900
+3,300
| +2% | +$36.2K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $1.89M | Hold |
203,600
| – | – | ﹤0.01% | 1900 |
|
|
2024
Q2 | $1.89M | Buy |
+203,600
| New | +$1.84M | ﹤0.01% | 1847 |
|
|
2023
Q4 | – | Sell |
-101,200
| Closed | -$537K | – | 2542 |
|
|
2023
Q3 | $537K | Buy |
101,200
+9,100
| +10% | +$77.4K | ﹤0.01% | 2496 |
|
|
2023
Q2 | $878K | Hold |
92,100
| – | – | ﹤0.01% | 2362 |
|
|
2023
Q1 | $1.01M | Sell |
92,100
-9,600
| -9% | -$139K | ﹤0.01% | 2244 |
|
|
2022
Q4 | $1.51M | Buy |
101,700
+3,900
| +4% | +$68.1K | ﹤0.01% | 2073 |
|
|
2022
Q3 | $1.87M | Buy |
97,800
+26,600
| +37% | +$603K | ﹤0.01% | 1916 |
|
|
2022
Q2 | $1.52M | Buy |
71,200
+11,700
| +20% | +$240K | ﹤0.01% | 2109 |
|
|
2022
Q1 | $1.15M | Buy |
59,500
+4,300
| +8% | +$72.7K | ﹤0.01% | 2341 |
|
|
2021
Q4 | $1.15M | Hold |
55,200
| – | – | ﹤0.01% | 2398 |
|
|
2021
Q3 | $1.32M | Hold |
55,200
| – | – | ﹤0.01% | 2294 |
|
|
2021
Q2 | $1.51M | Sell |
55,200
-1,000
| -2% | -$28.2K | ﹤0.01% | 2277 |
|
|
2021
Q1 | $1.63M | Buy |
56,200
+31,900
| +131% | +$996K | ﹤0.01% | 2126 |
|
|
2020
Q4 | $684K | Buy |
24,300
+3,000
| +14% | +$73.5K | ﹤0.01% | 2417 |
|
|
2020
Q3 | $624K | Hold |
21,300
| – | – | ﹤0.01% | 2304 |
|
|
2020
Q2 | $644K | Buy |
+21,300
| New | +$616K | ﹤0.01% | 2309 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
